Technology | August 25, 2014

FDA Clears Siemens’ Third-generation Iterative Reconstruction CT Software

August 25, 2014 — Siemens Healthcare has received 510(k) clearance from the Food and Drug Administration (FDA) for ADMIRE (Advanced Modeled Iterative Reconstruction), the company’s new image reconstruction algorithm for computed tomography (CT). ADMIRE supplements SAFIRE (Sinogram Affirmed Iterative Reconstruction), Siemens’ raw-data based iterative reconstruction algorithm, which can provide a radiation dose reduction of up to 60 percent. The goal in CT imaging is to use a dose level that is as low as reasonably achievable. Low-dose imaging is sometimes limited because using less radiation tends to reduce image quality. ADMIRE improves reconstructed image quality and can result in images with a natural image impression, thus enabling previously unachievable low-dose imaging in many studies.

Now available on the Somatom Force — Siemens’ new dual-source CT system — ADMIRE uses additional modeling loops that help deliver improved resolution at high contrast edges. With the combination of SAFIRE, ADMIRE and the technology in the SOMATOM Force, Siemens can deliver studies at very low doses that maintain image quality and preserve image impression.

For more information: www.siemens.com/healthcare

Related Content

IBA Announces First Use of Gating With Active Scanning Proton Therapy in Italy
News | Proton Therapy | October 17, 2017
October 17, 2017 — The Trento Azienda Provinciale per i Servizi Sanitari (APSS) and IBA announced the successful comp
Infinitt Adds Organ Dose Data to Radiation Dose Management Solution
Technology | Radiation Dose Management | October 10, 2017
October 10, 2017 — Infinitt announced that its DoseM web-based...
Carestream Showcases Imaging and Healthcare IT Systems at RSNA 2017
News | Information Technology | October 10, 2017
October 10, 2017 — Carestream will be highlighting several of its imaging systems and healthcare...
Medis Releases QAngio CT v3.1
Technology | Computed Tomography (CT) | October 09, 2017
October 9, 2017 — Medis has released a new version of its QAngio...
CompleWare and Vida Announce Joint Marketing Agreement for Respiratory Trials
News | Lung Cancer | October 05, 2017
October 5, 2017 — CompleWare and Vida recently announced a joint marketing agreement promoting complementary respirat
Toshiba's Aquilion One Genesis CT Offers New Advances for Emergency Department Imaging
News | Computed Tomography (CT) | October 02, 2017
Healthcare providers now have access to fast and safe emergency department (ED) computed tomography (CT) imaging with...
Biomarker Blood Test Predicts Survival Following Localized Lung Cancer Treatment
News | Lung Cancer | September 29, 2017
A new study demonstrates that a blood test to detect cancer may predict treatment outcomes for patients with localized...
Toshiba Highlights Interventional Imaging at RSNA 2017
News | Interventional Radiology | September 27, 2017
Toshiba Medical announced it will highlight several of its latest vascular and interventional imaging solutions at the...
Cincinnati Children's Acquires Toshiba Aquilion One Genesis CT for Pediatric Care
News | Computed Tomography (CT) | September 26, 2017
September 26, 2017 — Patients at Cincinnati Children’s Hospital Medical Center now have access to the latest in dynam
Toshiba Medical Demonstrates Radiation Therapy Planning Enhancements for Aquilion LB CT at ASTRO
News | Computed Tomography (CT) | September 25, 2017
September 25, 2017 — Toshiba Medical will showcase new advanced technology on its Aquilion LB...
Overlay Init